Thrombin regulates matrix metalloproteinase-9 expression in human monocytes

Biochemical and Biophysical Research Communications

Volumn 385, Issue 2, 2009, Pages 241-246

  Chang, Chi Jen ^a   Hsu, Lung An ^a   Ko, Yu Hsein ^a   Chen, Pei Ling ^a   Chuang, Yi Ting ^a   Lin, Chun Yen ^a   Liao, Chang Hui ^a   Pang, Jong Hwei S ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Matrix metalloproteinase; Monocytes; Thrombin

Indexed keywords

CALCIUM CHELATING AGENT; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROTEIN ANTIBODY; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 3; THROMBIN; THROMBIN RECEPTOR;

ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; ENZYME REGULATION; ENZYME RELEASE; GEL MOBILITY SHIFT ASSAY; HUMAN; MONOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

CALCIUM; CHELATING AGENTS; EGTAZIC ACID; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MONOCYTES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; THROMBIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 67349262456     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.05.049     Document Type: Article

References (19)

1. Galis Z.S., Sukhova G.K., Lark M.W., and Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94 (1994) 2493-2503
2. Lee R.T., Schoen F.J., Loree H.M., Lark M.W., and Libby P. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis: implication for plaque rupture. Arterioscler. Thromb. Vasc. Biol. 16 (1996) 1070-1073
3. Shah P.K., Falk E., Badimon J.J., Fernandez-Ortiz A., Mailhac A., Villareal-Levy G., Fallon J.T., Regnstrom J., and Fuster V. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92 (1995) 1565-1569
4. Sukhova G.K., Schonbeck U., Rabkin E., Schoen F.J., Poole A.R., Billinghurst R.C., and Libby P. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 99 (1999) 2503-2509
5. Galis Z.S., Sukhova G.K., Kranzhöfer R., Clark S., and Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc. Natl. Acad. Sci. USA 92 (1995) 402-406
6. Gough P.J., Gomez I.G., Wille P.T., and Raines E.W. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J. Clin. Invest. 116 (2006) 59-69
7. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90 (2002) 251-262
8. Fontaine V., Jacob M.P., Houard X., Rossignol P., Plissonnier D., Angles-Cano E., and Michel J.B. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am. J. Pathol. 161 (2002) 1701-1710
9. Chang C.J., Ko Y.S., Ko P.J., Hsu L.A., Chen C.F., Yang C.W., Hsu T.S., and Pang J.H. Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity. Kidney Int. 68 (2005) 1312-1319
10. Miltenyi S., Muller W., Weichel W., and Radbruch A. High gradient magnetic cell separation with MACS. Cytometry 11 (1990) 231-238
11. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260 (1985) 3440-3450
12. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
13. Colognato R., Slupsky J.R., Jendrach M., Burysek L., Syrovets T., and Simmet T. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells. Blood 102 (2003) 2645-2652
14. Liu Y., Gilcrease M.Z., Henderson Y., Yuan X.H., Clayman G.L., and Chen Z. Expression of protease-activated receptor 1 in oral squamous cell carcinoma. Cancer Lett. 169 (2001) 173-180
15. Wang L., Luo J., and He S. Induction of MMP-9 release from human dermal fibroblasts by thrombin: involvement of JAK/STAT3 signaling pathway in MMP-9 release. BMC Cell Biol. 8 (2007) 14
16. Liu W.H., Chen X.M., and Fu B. Thrombin stimulates MMP-9 mRNA expression through AP-1 pathway in human mesangial cells. Acta Pharmacol. Sin. 21 (2000) 641-645
17. 2 as a trigger and NF-kappaB as a signal transducer. Thromb. Haemost. 90 (2003) 528-537
18. Fabunmi R.P., Baker A.H., Murray E.J., Booth R.F., and Newby A.C. Divergent regulation by growth factors and cytokines of 95 and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem. J. 315 Pt 1 (1996) 335-342
19. Bea F., Kreuzer J., Preusch M., Schaab S., Isermann B., Rosenfeld M.E., Katus H., and Blessing E. Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2787-2792